Social Media

MM&M's top 5 stories in November 2016

MM&M's top 5 stories in November 2016

By

How VR, nanotechnology, and 3D printing could improve the value of healthcare; 100 experimental therapies in late-stage clinical trials; Kite Pharma plans "controlled" launch of CAR-T therapy

How Duchesnay USA got over the Kardashian marketing bump

How Duchesnay USA got over the Kardashian marketing bump

By

The drugmaker still views Instagram as a viable marketing platform, however.

10 things for pharma marketers to know about Facebook and Instagram

10 things for pharma marketers to know about Facebook and Instagram

By

With about 70 million users in six million health-related groups, drugmakers have tremendous opportunity to reach key audiences on Facebook. Here's how.

Five things for pharma marketers to know: Tuesday, November 1, 2016

Five things for pharma marketers to know: Tuesday, November 1, 2016

By

Facebook opens up to pharma; Pfizer nixes PCSK9 inhibitor in development; Cardinal Health cuts forecast on dwindling price increases

Warning letters most often stem from missing risk information

Warning letters most often stem from missing risk information

By

The number of warning and untitled letters has dropped in recent years. Only four letters have been sent so far this year, compared to 28 in 2012.

Why Excedrin embraced the headache of a contentious election season

Why Excedrin embraced the headache of a contentious election season

By

Excedrin's #DebateHeadache was inspired by complaints the brand noticed during the first presidential debate in September.

Five things for pharma marketers to know: Wednesday, October 19, 2016

Five things for pharma marketers to know: Wednesday, October 19, 2016

By

Roche gets FDA approval for immunotherapy Tecentriq; insurers are sued for discrimination; the FDA proposes yanking generic ADHD drugs from market

Best Use of Social Media of 2016

Best Use of Social Media of 2016

By

Digitas Health LifeBrands used Snapchat and Twitter to drive immuno­deficiency patient Seth's story. The effort garnered 188 million impressions for #wearyellowforseth.

MM&M's 5 most popular stories in September 2016

MM&M's 5 most popular stories in September 2016

By

Physicians are seeking beyond-the-pill services from drugmakers; Novartis debunks misconception that only smokers get lung cancer; pharma's access to docs declines

Why the FDA's view of patient communication evolved over time

Why the FDA's view of patient communication evolved over time

By

The agency's ambitions were fueled in part by external criticism. The barbs that stung most sharply were ones suggesting a certain indifference on the FDA's part.

Which drugmakers have the healthiest presence on social media?

Which drugmakers have the healthiest presence on social media?

By

A study of the social media activity of pharmaceutical firms finds that Lilly is the most active, but Novo Nordisk and Boehringer Ingelheim have better engagement.

On Facebook, 97% of brands still rely on organic reach, says BBDO study

On Facebook, 97% of brands still rely on organic reach, says BBDO study

By

For years the social network has been telling advertisers they must pay to magnify their exposure, but most continue to resist.

Anti-smoking group Truth releases musical FOMO spot for MTV Video Music Awards

Anti-smoking group Truth releases musical FOMO spot for MTV Video Music Awards

By

The anti-tobacco movement Truth is hitting young people in their pocketbooks with a new spot called "Squadless."

8 ways for pharma to improve the way it uses Twitter

8 ways for pharma to improve the way it uses Twitter

By

Twitter's health team offers advice on how pharma and healthcare companies can more effectively utilize 140 characters.

AstraZeneca pulls Take it From a Fish campaign

AstraZeneca pulls Take it From a Fish campaign

By

The unbranded campaign won the top prize at the 2015 Lions Health festival in Cannes.

Using humor: Why pharma doesn't need to fear social media

Using humor: Why pharma doesn't need to fear social media

By

Healthcare and tech executives say it's possible for pharma to engage, use humor, and have fun on social media.

Sermo opens up platform to healthcare marketers

Sermo opens up platform to healthcare marketers

By

The Facebook for doctors launches Pages, allowing healthcare companies to establish a presence on Sermo and engage with physicians.

Twitter, Facebook, Google execs examine regulatory limits for drugmakers

Twitter, Facebook, Google execs examine regulatory limits for drugmakers

By

Technology executives discussed how pharma companies can leverage social media to better engage with patients online.

'Deadpool' Imparts a Lesson to Pharma Marketers

'Deadpool' Imparts a Lesson to Pharma Marketers

Social is a big deal in healthcare. Marketers can use it to create positive chatter and win greater awareness, recognition, and credibility among target audiences.

Marketers Rely on Email and Social Media, Rather than Face Time

Marketers Rely on Email and Social Media, Rather than Face Time

Curating personal relationships is one of the most valuable functions medical marketers can provide. The best way is through face-to-face interaction.

Pharma companies turn to LinkedIn to engage

Pharma companies turn to LinkedIn to engage

By

Part of LinkedIn's appeal lies in the high level of engagement of its members and the potential for precise targeting of content and talent searches.

Leadership Exchange: Social Listening

Leadership Exchange: Social Listening

By

Social listening can help all along the value chain—from research and discovery to developing marketing plans and strategy.

Why UCB isn't afraid of social media

Why UCB isn't afraid of social media

By

The company "embraces" adverse-event reporting and knows not to expect monetary ROI from unbranded initiatives, says its US-based social media lead.

Five things for pharma marketers to know: Wednesday, November 4, 2015

Five things for pharma marketers to know: Wednesday, November 4, 2015

By

Many patients allow doctors to access their social-media accounts; Turing will reportedly lower the price of Daraprim by 10%; WebMD reports boost in traffic

How To Fix The 'Problems' With Social Listening

How To Fix The 'Problems' With Social Listening

Work hard to get everyone in your company to understand what you can learn from social listening—you'll know you're successful when inquisitive minds throughout the company start asking you the question, "Can we find out what patients are saying about this brand online?"

Omitting risk info in ads is top reason for FDA warning

Omitting risk info in ads is top reason for FDA warning

By

An analysis conducted by J&J executives found that 58% of FDA warning letters and untitled letters over the last two years omitted risk information.

Bristol-Myers Squibb promotes employees

Bristol-Myers Squibb promotes employees

By

The drugmaker launched its first YouTube channel as it kicked off the campaign.

Pfizer's Susman: Customer-company relationship has changed

Pfizer's Susman: Customer-company relationship has changed

By

Stakeholder activists, social media and an increasingly global market are three defining issues for companies operating in the 21st century.

Is It Finally Time for Pharma to Change the Way It Uses Facebook?

Is It Finally Time for Pharma to Change the Way It Uses Facebook?

Pharma has hidden behind the ability to turn commenting off on Facebook pages, allowing marketers to use the channel much as they would a typical web page.

Five things for pharma marketers to know: Monday, August 31

Five things for pharma marketers to know: Monday, August 31

By

Kim Kardashian posts corrective information on Instagram and Twitter; DPP-4 inhibitors are linked to joint pain; doctors question off-label prescriptions of PCSK9 inhibitors

OPINION

Email Newsletters